Cucurbiturils in Pharmaceutical Chemistry: Applications and Mechanistic Insights

What Are Cucurbiturils?

Cucurbiturils (CBs) are macrocyclic molecules composed of glycoluril units linked by methylene bridges, forming a rigid, barrel-shaped structure with a hydrophobic cavity and an entrance lined with polar carbonyl groups. They are usually composed of 5-10 glycoluril subunits (CB5-CB10) and are known for their chemical and thermal stability, adjustable cavity size, and excellent biocompatibility.

Fig.1 Chemical and model representations of CB_n^[1].

CBs have unique properties that set them apart from traditional drug delivery systems like dendrimers, liposomes, hydrogels, micelles, carbon nanotubes, or synthetic polymers. They are characterized by their very high encapsulation affinity and the ability to precisely control the guest molecules. For example, the binding constant of CB7 is higher than that of the natural biotin-avidin complex (7.2 × 10¹⁷ M⁻¹ for adamantane derivative), demonstrating the exceptional affinity of cucurbiturils. These properties make CBs highly attractive for applications in drug delivery and formulation. They can encapsulate small organic molecules, peptides, proteins, and ions, protecting them from degradation and improving drug solubility, bioavailability, and pharmacokinetic properties.

Fig.2 Binding constants of different guests with CB[7]^[2].

Alfa Chemistry provides an extensive selection of cucurbiturils and their derivatives for high-end pharmaceutical research. View and purchase now!

Catalog Number	Product Name
ACM1224882761	Cucurbit[8]uril
ACM2497441822	rac-Acyclic cucurbit[n]uril
ACM259886492	Cucurbit[5]uril
ACM307001509	Cucurbit[10]uril
ACM80262448-2	Cucurbituril, 98%

How Do Cucurbiturils Enhance Drug Solubility and Stability?

The hydrophobic cavity of CB can envelop a poorly soluble drug molecule, increase its solubility in water, and prevent aggregation. For instance, CB7 is able to enhance the solubility of albendazole by nearly 2,000-fold. Cucurbiturils can also stabilize the amorphous form of drugs, like thiabendazole and mebendazole, to prevent polymorphic phase transitions. Such CB-mediated encapsulation of drugs often results in a shift in the pKa of the protonated guest molecule, stabilizing the active form at physiological pH. For sanguinarine, the pK_a of the alcoholamine in the encapsulated complex shifts from 7.2 to 10.8 with CB7, stabilizing it in a weakly alkaline form that is biologically active.

Drug	CB Host	Solubility Enhancement	Stability Enhancement	Notes
Albendazole	CB7	2000×	Maintains amorphous form	Protonated form preferential binding
Sanguinarine	CB7	Moderate	Light and pH stability	pKa shift stabilizes active form
Berberine	CB7	High	Fluorescence enhancement ×500	Forms 1:1 complex; CB8 encapsulates 2 units
Mitoxantrone	CB8	Moderate	Reduced toxicity, enhanced uptake	Forms 2:1 host–guest complex

What Types of Drugs Can Cucurbiturils Encapsulate?

Numerous studies have demonstrated that cucurbiturils can encapsulate a variety of bioactive molecules. Alfa Chemistry has compiled a list of encapsulated drugs for reference:

• Anticancer drugs: mitoxantrone, capecitabine, platinum drugs, paclitaxel derivatives
• Antibacterial drugs: berberine, sanguinarine, albendazole
• Local anesthetics: procaine, tetracaine, benzocaine
• Neuroactive compounds: nicotine, tolpyramine
• Enzyme inhibitors and hormones: various small molecule inhibitors and steroid hormones

Encapsulation can enhance solubility, reduce off-target interactions, improve chemical stability, and modulate pharmacokinetics, thereby achieving controlled and efficient drug delivery.

Fig.3 Chemical structures of benzimidazole derivatives and alkaloids that form host-guest complexes with CB_n^[3].

How to Control Drug Release from Cucurbituril Complexes?

A. Dilution and Kinetics

The release of a drug from a cucurbituril complex often occurs in a rapid association-dissociation kinetic manner. Due to a phenomenon called the dilution effect, the weakly associated complexes dissociate spontaneously in complex biological fluids. For example, albendazole was released from CB7 within seconds of reaction. Ruthenium complexes in large cucurbiturils (e.g., CB10) have a release profile in the range of hours, which would be advantageous for sustained drug release applications.

B. pH-Responsive Release

Release of CB-drug complexes can be achieved by pH-responsive release triggered by pH changes around the neutral pH range. The assembly and disassembly of CB-guest complexes can modulate the pKa of the guest itself. In general, the coating of a molecule in CB leads to an increase in pKa of the basic guest molecule. Disruption of the complex by a change in pH of the medium results in the liberation of the drug. Surface-functionalized nanoparticles, equipped with CB6-based pseudorotaxane valves show pH-dependent, controlled release profiles and selective delivery in the acidic tumor microenvironment.

C. Competitive Displacement

Drug release from a cucurbituril complex can be triggered by inorganic cations or competing guest molecules, which can then effectively occupy the CB channel. The aliphatic amine-modified gold nanoparticles (AuNPs) could be replaced by 1-ADAMANTANAMINE (ADA) on CB7. The selective uptake of the ADA@CB7@AuNP complexes, as well as their corresponding cytotoxicity against cancer cells, was increased in comparison to their AuNP counterparts. Multimodal competitive substitution strategies are widening the field of spatially and temporally controlled drug delivery.

Fig.4 Leveraging the powerful selective recognition properties of cucurbituril macrocycles, we achieve remarkable control over the properties of gold nanoparticles in living cells. Competitive host-guest complexation between ADA and CB[7] is used for selective NP property transformation. a) Intracellular decomplexation of AuNP4·CB[7] reveals cytotoxic AuNP-4. b) Intracellular removal of CB[7] provides access to monolayer-embedded catalysts for prodrug activation^[3].

D. Light-Triggered Release

CB complexes can be engineered for photoresponsive drug release, either by light-induced changes in pH or by photoconversion of the guest molecule itself. The DNA-intercalator, Hoechst 33258, can be loaded in CB7 and released by irradiation with UV-light via an MGOH-mediated pH increase. Photoinduced conversion can also be applied for the memantine derivative, which is then released from CB7 or CB8.

E. Microheterostructured and Nanostructured Systems

CB-based microheterostructured and nanostructured assemblies, such as vesicles, hydrogels, and supramolecular polymers can encapsulate drugs and have triggered release of the cargo in response to stimuli. The nanoassemblies of CB7/BSA in the presence of doxorubicin show pH- and competitive drug-triggered release, selectively regaining the drug's cytotoxicity in the target location. CB8-mediated supramolecular micelles enable precise intracellular delivery of chemotherapeutic drugs by combining thermal, pH and competitive triggering.

Fig.5 Typical CB‐based nanoarchitectures: a) molecular structures of CB[n]s (n=6, 7, and 8), b) a (pseudo)rotaxane, c) an oligomeric complex, d) an amphiphile, e) a cross‐linked network, and f) a supramolecular organic framework^[4].

How Do Cucurbiturils Mitigate Drug Toxicity and Side Effects?

CB encapsulation can mask toxic functional groups, reduce off-target interactions, and modulate pharmacodynamics. CB7 complexes have been shown to:

• Reduce the cytotoxicity of polycationic carriers such as polyethyleneimine
• Mitigate the in vitro and in vivo toxicity of the herbicide (paraquat)
• Suppress small neuroactive molecule-induced seizures in zebrafish and mouse models
• Regulate coagulation by sequestering harmful compounds (e.g., hexabromocyclododecane)
• Mask bitter taste, improving oral bioavailability and patient compliance

How Can Cucurbituril-based Systems Be Designed for Targeted Drug Delivery?

Targeted drug delivery remains a key challenge in medicinal chemistry, requiring the precise delivery of therapeutics to diseased cells while minimizing off-target effects. Cucurbituril-based systems have emerged as highly versatile platforms to achieve this goal, leveraging unique host-guest chemistry and tunable functionalization capabilities.

A. Functionalization for Receptor-Mediated Targeting

CB derivatives can be functionalized with moieties that specifically recognize cell surface receptors, enabling selective binding and internalization. A notable example is the synthesis of vesicle-forming CB6 derivatives, whose surfaces are modified with α-mannose-spermidine conjugates, attached via thiourea linkages. These vesicles selectively aggregate in the presence of concanavalin A (ConA), a lectin highly specific for α-mannose, but do not aggregate when galactose derivatives are substituted, demonstrating their potential for receptor-specific targeting^[5].

B. Glycan and Peptide Functionalized Targeting

In addition to folate, CB6-carbohydrate conjugates can also be targeted to cells expressing specific lectin receptors. For example, galactose-functionalized CB6 nanoparticles promote ASGPR-mediated endocytosis in hepatocytes^[6]. CB6 vesicles containing a disulfide-bridged polymer network can respond to intracellular reducing conditions (e.g., DTT treatment) and release their encapsulated payload upon disulfide bond cleavage. The introduction of galactose-spermidine groups onto the vesicle surface enables simultaneous targeting and payload delivery, as demonstrated using fluorescent probes such as carboxyfluorescein in HepG2 cells.

Peptide-functionalized CB6-hyaluronic acid (CB6-HA) conjugates offer a higher level of targeting specificity. The peptide-spermidine unit non-covalently binds to CB6-HA, selectively delivering the payload to cells expressing the formyl peptide receptor (FPRL1). In vitro imaging demonstrated controlled delivery of the payload to B16F1 and MCF-7 cells using the FITC-labeled probe. Functional activation of FPRL1 was also confirmed by intracellular Ca²⁺ signaling, demonstrating receptor-mediated targeting and retention of functional bioactivity.

• Mechanistic Elucidation and Therapeutic Implications

Taken together, these CB-based systems have begun to shed light on combining the host-guest chemistry with functional targeting for selective uptake. Prominent features and mechanisms include:

• Receptor-mediated endocytosis through carbohydrate or folate recognition
• Cleavable disulfide bonds for redox-responsive release
• Non-covalent peptide coupling for receptor activation and signal-based tracking

The inherently modular nature of CB chemistry allows for simultaneous and efficient incorporation of imaging, targeting, and therapeutic functions, with the end result being a series of true multifunctional "magic bullet" systems.

Conclusion

Cucurbiturils serve as a modular platform in medicinal chemistry that can be readily used to enhance solubility, stability, controlled release, and reduce the toxicity of a broad class of drugs. At Alfa Chemistry we provide the next generation of cucurbiturils and their derivatives to researchers to best support their drug delivery research and enable novel therapeutic development.

Clients exploring melitracen hydrochloride may also find value in our following products:

References

1. Das D, et al. Applications of Cucurbiturils in Medicinal Chemistry and Chemical Biology. Front Chem.(2019).
2. Späth A, et al. ChemInform Abstract: Molecular Recognition of Organic Ammonium Ions in Solution Using Synthetic Receptors. Beilstein Journal of Organic Chemistry.(2010).
3. William E, et al. Manipulating the Monolayer: Responsive and Reversible Control of Colloidal Inorganic Nanoparticle Properties. ChemNanoMat.(2016).
4. Liu Y-H, et al. Cucurbituril‐Based Biomacromolecular Assemblies. Angewandte Chemie International Edition.(2020).
5. Lee HK, et al. Vesicle formed by amphiphilc cucurbit[6]uril: versatile, noncovalent modification of the vesicle surface, and multivalent binding of sugar-decorated vesicles to lectin. J. Am. Chem. Soc.(2005).
6. Kim E, et al. Facile, template-free synthesis of stimuli-responsive polymer nanocapsules for targeted drug delivery. Angew. Chem. Int. Ed.(2010b).

Please kindly note that our products are for research use only.